HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans-Christoph Diener Selected Research

Dipyridamole (Persantine)

1/2019Antiplatelet Therapy After Noncardioembolic Stroke.
7/2016Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
1/2012Antiplatelet therapy in cerebrovascular disorders.
11/2010Antiplatelet therapy in secondary stroke prevention--state of the art.
4/2010Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
2/2010Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
8/2009Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
10/2008Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
9/2008Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
9/2007The PRoFESS trial: future impact on secondary stroke prevention.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans-Christoph Diener Research Topics

Disease

147Stroke (Strokes)
06/2022 - 09/2001
91Migraine Disorders (Migraine)
05/2022 - 01/2002
76Ischemic Stroke
05/2022 - 09/2001
72Hemorrhage
06/2022 - 09/2001
69Atrial Fibrillation
05/2022 - 02/2005
57Headache (Headaches)
10/2021 - 01/2002
30Pain (Aches)
01/2021 - 01/2002
18Myocardial Infarction
05/2022 - 09/2001
18Embolism (Embolus)
01/2021 - 08/2004
15Cluster Headache (Cluster Headaches)
01/2021 - 07/2007
14Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020 - 02/2006
13Embolic Stroke
06/2022 - 08/2009
13Hypertension (High Blood Pressure)
01/2020 - 12/2003
13Transient Ischemic Attack
01/2019 - 09/2001
11Secondary Headache Disorders
10/2021 - 11/2002
8Cerebral Hemorrhage
01/2020 - 03/2007
8Epilepsy (Aura)
10/2019 - 01/2002
8Infarction (Infarctions)
08/2019 - 01/2002
8Tension-Type Headache (Tension Headache)
03/2019 - 11/2002
7Peripheral Arterial Disease
01/2022 - 09/2001
7Nausea
07/2021 - 01/2002
7Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2019 - 01/2004
6Headache Disorders (Headache Syndromes)
10/2022 - 03/2009
6Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 01/2007
6Cardiovascular Diseases (Cardiovascular Disease)
03/2015 - 03/2005
5Thrombosis (Thrombus)
01/2022 - 01/2004
5Patent Foramen Ovale
01/2021 - 01/2012
5Diabetes Mellitus
01/2020 - 07/2010
5Prescription Drug Overuse
01/2019 - 11/2002
5Cognitive Dysfunction
03/2015 - 12/2003
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 10/2015
4Hyperacusis (Phonophobia)
07/2021 - 01/2002
4Photophobia (Light Sensitivity)
07/2021 - 01/2002
4Heart Failure
10/2020 - 01/2007
4Vascular Diseases (Vascular Disease)
01/2020 - 08/2004
4Coronary Disease (Coronary Heart Disease)
01/2017 - 09/2001
4Hemorrhagic Stroke
12/2012 - 03/2007
3Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2022 - 10/2018
3Pathologic Constriction (Stenosis)
01/2020 - 02/2006
3Cerebral Infarction
01/2019 - 01/2016
3Thromboembolism
04/2018 - 02/2005

Drug/Important Bio-Agent (IBA)

59Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2022 - 09/2001
45AnticoagulantsIBA
01/2022 - 02/2005
35Vitamin KFDA Link
05/2022 - 10/2010
34DabigatranFDA Link
06/2022 - 09/2009
29Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 09/2001
25Pharmaceutical PreparationsIBA
10/2022 - 05/2002
24Tryptamines (Triptans)IBA
01/2021 - 01/2002
24Clopidogrel (Plavix)FDA Link
01/2019 - 09/2001
20Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 09/2001
18Tissue Plasminogen Activator (Alteplase)FDA Link
01/2022 - 10/2002
17Dipyridamole (Persantine)FDA LinkGeneric
01/2019 - 09/2001
15Pain-FreeIBA
05/2017 - 02/2004
14Topiramate (Topamax)FDA LinkGeneric
01/2018 - 08/2004
13Type A Botulinum Toxins (Botox)FDA Link
12/2020 - 01/2008
13Caffeine (No Doz)FDA LinkGeneric
10/2017 - 01/2002
12Analgesics (Analgesic Drugs)IBA
01/2019 - 08/2004
11N(4)-oleylcytosine arabinosideIBA
08/2021 - 07/2013
9apixabanIBA
05/2022 - 03/2011
9Calcitonin Gene-Related PeptideIBA
01/2022 - 03/2004
9Telmisartan (Micardis)FDA Link
03/2015 - 01/2007
8Sumatriptan (Imigran)FDA LinkGeneric
01/2021 - 01/2002
7preemptIBA
12/2020 - 06/2010
7salicylhydroxamic acid (SHAM)IBA
10/2019 - 04/2006
7Angiotensin Receptor AntagonistsIBA
11/2009 - 03/2005
6ThrombinFDA Link
11/2021 - 02/2012
6Monoclonal AntibodiesIBA
10/2021 - 06/2017
6edoxabanIBA
01/2021 - 01/2017
6Acetaminophen (Paracetamol)FDA LinkGeneric
10/2017 - 05/2009
6Neuroprotective AgentsIBA
08/2011 - 12/2006
6almotriptan (Axert)FDA Link
10/2007 - 01/2005
5RivaroxabanIBA
06/2022 - 04/2012
5erenumabIBA
10/2021 - 01/2019
5zolmitriptan (Zomig)FDA Link
01/2021 - 01/2005
5Biological ProductsIBA
01/2021 - 01/2002
5Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2020 - 04/2011
5eletriptan (Relpax)FDA Link
04/2011 - 01/2002
5Free RadicalsIBA
06/2008 - 02/2006
5disufenton sodium (NXY 059)IBA
06/2008 - 02/2006
4Factor Xa InhibitorsIBA
01/2019 - 03/2012
4Ibuprofen (Motrin)FDA LinkGeneric
10/2017 - 03/2006
4Antihypertensive Agents (Antihypertensives)IBA
09/2012 - 12/2003
4AntithrombinsIBA
11/2011 - 02/2005
3Apolipoproteins B (ApoB)IBA
05/2022 - 07/2010
3LipidsIBA
05/2022 - 07/2006
3lasmiditanIBA
01/2022 - 10/2010
3eptinezumabIBA
10/2021 - 01/2020
3fremanezumabIBA
07/2021 - 11/2015
3Prednisone (Sone)FDA LinkGeneric
01/2021 - 02/2013
3Heparin (Liquaemin)FDA LinkGeneric
01/2021 - 01/2006

Therapy/Procedure

107Therapeutics
06/2022 - 01/2002
30Secondary Prevention
01/2022 - 09/2001
15Thrombectomy
01/2022 - 07/2013
8Stents
01/2017 - 05/2005
5Drug Therapy (Chemotherapy)
01/2021 - 07/2010
5Vagus Nerve Stimulation
10/2020 - 01/2016
5Contraindications
01/2020 - 08/2018
4Aftercare (After-Treatment)
05/2022 - 10/2002
4Electric Countershock (Cardioversion)
01/2021 - 10/2015
3Transcranial Direct Current Stimulation
10/2018 - 04/2011